FindTrial
Sign In

Hemodynamic values among women who have had their breasts removed, submitted or not to ILIB Therapy on the primitive carotid artery using Hormone Blockers

Hemodynamic variables among mastectomized women submitted or not to Transdermal Systemic Photobiomodulatory Therapy on the primitive carotid artery under the use of Hormone Blockers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7yyx66t
Enrollment
Unknown
Registered
2023-04-11
Start date
2022-02-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

This is an experimental, controlled and randomized clinical trial that aims to evaluate the hemodynamic variables of blood pressure and heart rate among patients undergoing Systemic Photobiomodulation
who are undergoing treatment at the Center for Rehabilitation and Research in Photobiomodulation of the Hospital de Câncer de Ribeirão Preto, undergoing hormonal treatment using Tamoxifen (TAM) and ar
who are undergoing treatment at the Center for Rehabilitation and Research in Photobiomodulation, Hospital de Câncer de Ribeirão Preto, undergoing treatment with hormone blockers, using TAM and AI, un
Group 2, Named
E02.594.540

Sponsors

Escola de Enfermagem de Ribeirão Preto - Universidade de São Paulo
Lead Sponsor
Hospital de Câncer de Ribeirão Preto - Sobeccan
Collaborator

Eligibility

Sex/Gender
Female
Age
30 Years to 85 Years

Inclusion criteria

Inclusion criteria: Women; mastectomized; aged between 30 and 85 years; submitted to hormonal treatment with the use of Tamoxifen and Aromatase Inhibitors

Exclusion criteria

Exclusion criteria: mastectomized women; pregnant women; glaucoma carriers; with implanted electronic devices; with active carcinomas of the head and pescoço; with epilepsy; seizures; under treatment of the thyroid gland; pediatric articular epiphysis; transplanted; photosensitive; recently subjected to treatment with steroids; recently subjected to treatment with botulinum toxin

Design outcomes

Primary

MeasureTime frame
The present study aims as a direct benefit the possible control of blood pressure and heart rate values in patients who use Tamoxifen and Aromatase Inhibitors, through the use of low intensity laser therapy in the artery located in the neck in hospital care. of cancer in Ribeirão Preto—

Secondary

MeasureTime frame
Secondary outcomes are not expected.—

Countries

Brazil

Contacts

Public ContactEugenia Veiga

Escola de Enfermagem de Ribeirão Preto Usp

cep@eerp.usp.br21(16) 3315-9197

Outcome results

None listed

Source: REBEC (via WHO ICTRP)